Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Telangiectasia, Hereditary Hemorrhagic D013683 1 associated lipids
Hemosiderosis D006486 1 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Roth S et al. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. 2008 Transl Res pmid:18061126
Liu Z et al. Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. 2008 Nucl Med Commun pmid:18094633
pmid:18118003
Hasegawa K et al. [Improvement of urinary d-glucaric acid assay and its application]. 2008 Yakugaku Zasshi pmid:18176065
Wall GC and Pauly RA Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. 2008 Am J Health Syst Pharm pmid:18192261
Pai AB et al. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. 2007 Clin Ther pmid:18201586
Al-Mueilo SH Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. 2005 Apr-Jun Saudi J Kidney Dis Transpl pmid:18202490
Al-Saran KA and Sabry AA Pregnancy in dialysis patients: a case series. 2008 J Med Case Rep pmid:18205953
pmid:18208026
Zolezzi M Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209437
Souqiyyeh MZ and Shaheen FA Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209438
Li H and Wang SX Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 Blood Purif. pmid:18212498
Jaber BL Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2008 Kidney Int. pmid:18235527
Bhatnagar R et al. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. 1991 Biochem. Pharmacol. pmid:1826840
Auerbach M and Al Talib K Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. 2008 Kidney Int. pmid:18274543
Earley CJ et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. 2009 Sleep Med. pmid:18280205
Li H and Wang SX Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. 2008 Mar-Apr Perit Dial Int pmid:18332450
Perek N et al. Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. 2008 Eur. J. Nucl. Med. Mol. Imaging pmid:18338166
Lim R et al. A permanent tan from iron. 2008 Kidney Int. pmid:18340355
Auerbach M et al. The role of intravenous iron in anemia management and transfusion avoidance. 2008 Transfusion pmid:18346021
Aghaie A et al. New insights into the alternative D-glucarate degradation pathway. 2008 J. Biol. Chem. pmid:18364348
pmid:18384797
Usmanov RI et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. 2008 Mar-Apr J. Nephrol. pmid:18446719
Willerson JT Detection of acute myocardial infarcts by infarct-avid imaging. 1991 J. Nucl. Med. pmid:1846912
Hedenus M and Birgegård G The role of iron supplementation during epoietin treatment for cancer-related anemia. 2009 Med. Oncol. pmid:18473194
Kuo KL et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. 2008 J. Am. Soc. Nephrol. pmid:18495964
Picker SM et al. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. 2008 Transfusion pmid:18513255
pmid:18571185
Cuenca J et al. Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. 2008 Anesthesiology pmid:18580186
Auerbach M and Ballard H Intravenous iron in oncology. 2008 J Natl Compr Canc Netw pmid:18597712
Pinsk V et al. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. 2008 Isr. Med. Assoc. J. pmid:18605353
Kaplinsky C Parenteral iron therapy. 2008 Isr. Med. Assoc. J. pmid:18605363
Costa S et al. In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. 2009 J Appl Toxicol pmid:18636399
Anirban G et al. The comparative safety of various intravenous iron preparations in chronic kidney disease patients. 2008 Ren Fail pmid:18661414
Oleson L and Court MH Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. 2008 J. Pharm. Pharmacol. pmid:18718121
pmid:18720044
pmid:18727354
Zółtaszek R et al. [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. 2008 Postepy Hig Med Dosw (Online) pmid:18772850
Stefánsson BV et al. Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. 2008 Free Radic. Biol. Med. pmid:18775775
pmid:18786076
Yang Z et al. Symbiosis between microorganisms from kombucha and kefir: Potential significance to the enhancement of kombucha function. 2010 Appl. Biochem. Biotechnol. pmid:18810658
pmid:18930421
Lord RS and Bralley JA Clinical applications of urinary organic acids. Part I: Detoxification markers. 2008 Altern Med Rev pmid:18950247
Young RS Determination of calcium oxide in calcined phosphate ores. 1973 Talanta pmid:18961359
Bolaños L et al. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. 2008 Adv Perit Dial pmid:18986009
Gonçalves P et al. The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. 2008 Nutr Neurosci pmid:19000377
Yoon SH et al. Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. 2009 J. Bacteriol. pmid:19060141
Moon TS et al. Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. 2009 Appl. Environ. Microbiol. pmid:19060162
pmid:19066859
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145